胸主动脉腔内修复术2区孤立左锁骨下动脉血运重建两种技术的比较
回顾性多中心观察研究纳入73例急慢性胸主动脉病变患者,在TEVAR 2区行孤立左锁骨下动脉血运重建,比较颈动脉-锁骨下动脉旁路(CSbp,n=42)与烟囱移植物(CGs,n=31)两种技术。两组早期TEVAR相关死亡率、卒中、Ia型内漏免除率及左锁骨下动脉通畅率无显著差异。
要点
- CSbp与CGs两组早期TEVAR相关死亡率分别为2%与6%,差异无统计学意义(p=0.571)。
- 两组各发生1例重大缺血性卒中,Ia型内漏免除率CSbp 98% vs CG 87%(p=0.134)。
- CG组4例(13%)出现与移植物间隙相关的内漏,但均无瘤囊增大、无再干预、无死亡。
核心结论
- 作者经验认为,CSbp与CGs两种左锁骨下动脉血运重建技术均令人满意且同等有效,中期随访未见可辨别的差异。
研究设计与样本
- 回顾性多中心观察性研究,纳入2010年1月至2017年2月期间73例(平均年龄68±13岁,范围22-87岁;56例男性)接受TEVAR联合孤立左锁骨下动脉血运重建的急慢性胸主动脉病变患者,其中CSbp组42例、CGs组31例。
主要发现
- 所有病例均获得初期技术成功。
- 早期TEVAR相关死亡率为4.2%(CSbp组2% vs CG组6%,p=0.571)。
- 2例(3%)患者发生重大缺血性卒中,每组各1例。
- 平均随访24±21个月(范围1-72个月;中位数15个月),估计12个月和36个月TEVAR相关死亡免除率为93%±3%(95%CI 84.3%至97.0%),CSbp与CG组间无显著差异(p=0.258)。
- 主动脉再干预率组间无差异(CSbp组5% vs CG组6%,p=0.356);Ia型内漏免除率亦无差异(CSbp组98% vs CG组87%,p=0.134)。CG组4例(13%)出现与移植物间隙相关的内漏,但均无瘤囊增大、无再干预需要、无死亡。观察期内全组左锁骨下动脉一期通畅率为100%。
关键数值与推荐
- 主要终点为TEVAR相关死亡、术后卒中、Ia型内漏免除率及左锁骨下动脉通畅率。
- 早期TEVAR相关死亡率:CSbp组2% vs CG组6%(p=0.571)。
- 重大缺血性卒中:每组各1例(共2例,3%)。
- Ia型内漏免除率:CSbp组98% vs CG组87%(p=0.134)。
- 主动脉再干预率:CSbp组5% vs CG组6%(p=0.356)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To analyze the results of isolated left subclavian artery (LSA) revascularization during thoracic endovascular aortic repair (TEVAR) using carotid-subclavian bypass (CSbp) or chimney grafts (CGs). METHODS: A retrospective multicenter, observational study identified 73 patients (mean age 68±13 years, range 22-87; 56 men) with acute or chronic thoracic aortic lesions who underwent TEVAR with isolated LSA revascularization using either CSbp (n=42) or CGs (n=31) from January 2010 and February 2017. Primary endpoints were TEVAR-related mortality, postoperative stroke, freedom from type Ia endoleak, and LSA patency. RESULTS: Primary technical success was achieved in all cases. Early TEVAR-related mortality was 4.2% (CSbp 2% vs CG 6%, p=0.571). Two (3%) patients had major ischemic strokes (one in each group). Mean follow-up was 24±21 months (range 1-72; median 15). Estimated freedom from TEVAR-related mortality was 93%±3% (95% CI 84.3% to 97.0%) at 12 and 36 months, with no significant difference between CSbp and CG (p=0.258). Aortic reintervention did not differ between the groups (CSbp 5% vs CG 6%, p=0.356); nor did freedom from type Ia endoleak (CSbp 98% vs CG 87%, p=0.134). Gutter-related endoleaks occurred in 4 (13%) CG patients, but none of the patients experienced sac enlargement or the need for reintervention and none died. Primary patency of the LSA was 100% for the entire group during the observation period. CONCLUSION: In our experience, LSA revascularization proved most satisfactory and equally effective with both the CSbp and CG techniques, without discernible differences at midterm follow-up.
引用
- Piffaretti G, Pratesi G, Gelpi G, et al. Comparison of Two Different Techniques for Isolated Left Subclavian Artery Revascularization During Thoracic Endovascular Aortic Repair in Zone 2. J Endovasc Ther. 2018. PMID: 30284491. doi:10.1177/1526602818802581
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。